Smart polymers and nanofibers are potentially intriguing materials for controlled release of bioactive agents. This work describes a new class of pH responsive nanofibers for drug delivery systems with controlled release properties. Initially, poly(4-vinylbenzoic acid-co-(ar-vinylbenzyl)trimethylammonium chloride)
Introduction
Controlled drug release systems have gained much attention in the last few decades and become an important topic in medicine, due to various advantages such as improved therapeutic efficacy and reduced toxicity by delivering the drug at controlled rates.
1-3 Several synthetic and/or natural polymers have been reported for controlled release studies. [4] [5] [6] In particular "smart" or "stimuli-responsive" polymers demonstrated their potential as effective carriers for controlled release. 7, 8 The characteristic feature that makes them smart is their ability to respond to the very slight changes in the environment such as temperature, pH, electric eld, light or magnetic eld. [8] [9] [10] In addition, the morphological form of the carrier matrix becomes a key factor affecting the release behavior. For instance, polymer based drug carriers can be broadly classied into one of the following categories: nanoparticles, nanogels, micelles, hydrogels and electrospun nanobers, each with certain advantages and disadvantages.
11
Electrospinning has become the most attractive nanober production technique in the past decade due to its cost-effectiveness and versatility. This technique facilitates the production of ultrane bers from a variety of materials such as polymers (synthetic and/or natural), polymer blends, sol-gels, composites, etc. [12] [13] [14] In the electrospinning process, a continuous lament is electrospun from polymer solutions or polymer melts under a very high electrical eld, which resulted in ultrane bers ranging from tens of nanometres to a few microns in diameter. Such nanobrous structures have been proposed for a number of applications due to their very high surface-to-volume ratio with highly porous structures.
12, 13 The morphology of electrospun nanobers can be controlled by optimizing the factors such as electrospinning process parameters, the polymer solution, and environmental conditions.
12,13
Further functionalizations of electrospun nanobers by physical/chemical post-treatments or incorporating active agents during the electrospinning process are also quite feasible for obtaining multifunctional nanobrous materials. Due to the exclusive properties of electrospun nanobers and their nanobrous webs, these are very promising candidates for membranes/lters, biotechnology, textiles, sensors, energy, electronics, and the environment.
12-21 Especially, electrospun nanobers can be ideal materials for drug delivery systems [20] [21] [22] [23] since encapsulation of drugs inside the nanober matrix can be readily achieved by electrospinning where the target drug is dissolved in the desired polymer solution. Numerous studies have described the preparation of electrospun nanobers containing pharmacologically active compounds and investigated the release characteristics of drugs. [22] [23] [24] [25] [26] [27] [28] [29] Yet, the studies dealing with the combination of pH responsive polymers and nanobers for the drug delivery systems are very limited in the literature.
30
In this study, we developed pH-responsive poly(4-vinylbenzoic acid-co-(ar-vinylbenzyl)trimethylammonium chloride) [poly(VBA-co-VBTAC)] nanobers for controlled drug release study. Poly(VBA-co-VBTAC) was synthesized via reversible addition-fragmentation chain transfer (RAFT) polymerization and pH responsive nanobers encapsulating ciprooxacin were produced by electrospinning. The morphological, structural and thermal characterization of the pH responsive nanobers were performed by using scanning electron microscopy (SEM), Fourier transform infrared (FTIR) and X-ray diffraction (XRD). In order to investigate the pH responsive behavior, the release prole of ciprooxacin from nanobers was examined under acidic, neutral and basic conditions. from a-bromo-p-toluic acid that was synthesized according to a previously published protocol.
Materials and methods

Materials
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Water was used from a Millipore Milli-Q ultrapure water system.
RAFT-mediated polymerization procedure
RAFT-mediated polymerization of VBA (30.0 mmol) and VBTAC (30.0 mmol) was performed with a 30 mL buffer solution (trisbuffered saline, pH ¼ 7.5), a free RAFT agent CPAD (0.3 mmol) and an initiator ACPA (0.06 mmol) at 0 C in a glass reactor. The solution was diluted to a 100 mL volume with a buffer solution and degassed by purging with nitrogen for 20 min. The polymerization solution was heated slowly (approximately 30 min) from 0 to 70 C.
The polymerization reaction solution (Fig. 1a) was stirred vigorously at 70 C under a nitrogen atmosphere. Aer polymerization reaction, poly(VBA-co-VBTAC), which was collected at the bottom of the glass reactor, was ltered and dried at room temperature under vacuum. The yield of poly(VBA-co-VBTAC) was determined gravimetrically. The molecular weight distribution of the polymer was measured by aqueous size exclusion chromatography (ASEC).
Electrospinning
Firstly, a clear solution of poly(VBA-co-VBTAC) was prepared by dissolving in a DMF-acetic acid (7/3) binary solvent mixture at 15% (w/v) polymer concentration. Then ciprooxacin was added into polymer solution at 5% (w/w, according to polymer). The ultimate ciprooxacin included and not-included polymer solution was placed in a 3 mL syringe tted with a metallic needle of 0.6 mm inner diameter. The syringe was xed horizontally on the syringe pump (KDS 101, KD Scientic). The electrode of a high-voltage power supply (Matsusada Precision, AU Series) was clamped to the metal needle tip, and the cylindrical aluminum collector was grounded (Fig. 1b) . The parameters of the electrospinning were adjusted as; feed rate of solutions ¼ 1 mL h À1 , the applied voltage ¼ 15 kV, and the tip-to-collector distance ¼ 10 cm. Electrospun nanobers were deposited on a grounded stationary cylindrical metal collector covered with a piece of aluminum foil. The electrospinning apparatus was enclosed in a Plexiglas box, and electrospinning was carried out at 25 C at 25% relative humidity. The collected nanobers were dried at room temperature under a fume hood overnight.
In vitro drug release studies
The release prole of ciprooxacin from pH responsive nanobers was investigated via high performance liquid chromatography (HPLC). A pH responsive nanobrous mat encapsulating ciprooxacin was immersed in 30 mL of releasing media (acetate buffer solution, phosphate buffered saline and tris-buffered saline) at 37 C for 720 minutes. 0.5 mL aliquot was withdrawn at predetermined time intervals up to 720 minutes and in order to keep the volume constant, the solution was replaced with the same volume of the fresh medium each time an aliquot was taken out (Fig. 1c) . To determine the loading efficiency of ciprooxacin in nanobers, a known weight of the sample was taken from three different parts of the nanobrous webs. These nanobers and a known amount of ciprooxacin were dissolved in dimethylformamideacetic acid (7/3) solution. The solutions were stirred at room temperature, 0.5 mL of aliquot was withdrawn and the total amount of ciprooxacin was determined by HPLC by three measurements. The HPLC results of nanobers were compared with those of ciprooxacin powder solution.
Measurements and characterization
The absolute molecular weights and dispersity of poly(VBA-co-VBTAC) were determined by ASEC at ambient temperature using Ultrahydrogel columns (120, 250, 500, and 1000Å; Waters), a Wyatt Technology Optilab T-rEX RI detector (l ¼ 690 nm), a Wyatt Technology Dawn Heleos II multiangle laser light scattering detector (l ¼ 658 nm), and 1 wt% acetic acid-0.1 M Na 2 SO 4 (aq.) as the eluent with a ow rate of 1.0 mL min À1 . The dn/dc value of poly(VBA-co-VBTAC) (0.161 mL g À1 )
in the above eluent was determined at 25 C with a Wyatt
Technology Optilab T-rEX RI detector (l ¼ 690 nm). The viscosity measurements of the electrospinning solutions were performed with a rheometer (Physica MCR 301, Anton Paar) equipped with a cone/plate accessory at a constant shear rate of 100 s À1 at 22 C. The morphology and the diameter of the poly(VBA-co-VBTAC) and ciprooxacin-loaded poly(VBA-co-VBTAC) [CIP-poly(VBA-co-VBTAC)] nanobers were examined by using a scanning electron microscope (FE-SEM) (FEI, Quanta 200 FEG). Samples were sputtered with 5 nm Au/Pd (PECS-682) and around 100 ber diameters were measured from the SEM images to calculate the average ber diameter of each sample. The infrared spectra of the samples were obtained by using a Fourier transform infrared spectrometer (FTIR) (Bruker-VERTEX 70). The samples were mixed with potassium bromide (KBr) and pressed as pellets. The scans (64 scans) were recorded between 4000 and 400 cm À1 at a resolution of 4 cm À1 . The X-ray diffraction (XRD) (PANalytical X'Pert Powder Diffractometer) patterns of nanobrous webs and ciprooxacin powder were collected by using Cu Ka radiation in a range of 2q ¼ 5-30 . The released amount of ciprooxacin from nanobers was determined by high performance liquid chromatography (HPLC, Agilent, 1200 series) coupled with a VWD UV detector. The column was C18 (Agilent, particle size: 5 mm; column dimension: 150 mm Â 4.6 mm) operating at 0.5 mL min À1 . The mobile phase for separation was 100% acetonitrile. The injection volume was 5 mL. The UV detector was set at 217 nm. The experiments were carried out in triplicate and the results were given as the average AE standard deviation.
Results and discussion
Preparation and characterization of pH responsive nanobers
Poly(VBA-co-VBTAC) with 52% VBA content 33 was synthesized via RAFT polymerization. We prepared copolymers with relatively large molecular weights (approximately 32 000 g mol À1 , yield 86%, DI ¼ 1.08) to obtain uniform nanobers. The overall procedure to prepare pH responsive nanobers is described in Fig. 1 . The morphological properties of the prepared nanobers were observed using SEM (Fig. 2) . SEM imaging showed that the electrospun poly(VBA-co-VBTAC) nanobers and ciprooxacin encapsulated poly(VBA-co-VBTAC) (poly(VBA-co-VBTAC)/ciprooxacin) nanobers were bead-free and have a smooth morphology with an average ber diameter (AFD) of 310 AE 65 and 445 AE 120 nm, respectively. The poly(VBA-co-VBTAC)/ciprooxacin nanobers have higher ber diameter compared to poly(VBA-co-VBTAC) nanobers because the viscosity of the solution increased from 0.38 Pa$s to 0.59 Pa$s when ciprooxacin was added into the polymer solution (Table 1) . So, the electried jet is subjected to less stretching during the electrospinning process and thicker nanobers were obtained.
12,34 Fig. 2 shows the optical images of pH responsive nanobers before and aer swelling in deionized water. The nanobers were initially opaque and became translucent upon absorption of water. Fig. 2 The representative SEM images of (a) poly(VBA-co-VBTAC) nanofibers and (b) fiber diameter distribution; (c) poly(VBA-co-VBTAC)/ciprofloxacin nanofibers and (d) fiber diameter distribution; photographs of poly(VBA-co-VBTAC) nanofibrous mat (e) before and (f) after swelling in deionized water. Fig. 3 shows the FTIR spectra of the ciprooxacin and the electrospun nanobers. The characteristic band of ciprooxacin was observed at 1624 and 1272 cm À1 due to the vibration of phenyl framework conjugated to -COOH and the stretching vibration of the C-F bond, respectively. FTIR spectra of ciprooxacin also showed an absorbance band at 3083 and 2918 cm À1 for the C-H stretching from the phenyl ring. 35, 36 The peaks at 1670, 1480 and 1409 cm À1 were assigned to carbonyl
(C]O), scissor -CH 2 -vibration and asymmetric -CH 3 deformation vibration of the poly(VBA-co-VBTAC) nanobers, respectively. Through the FTIR spectra of poly(VBA-co-VBTAC)/ ciprooxacin nanobers, it can be seen that absorption maxima of stretching vibration shied toward lower wavenumbers compared to the pure ciprooxacin and poly(VBA-co-VBTAC) nanobers. All these results indicated that the model drug used in this work had strong hydrogen bonds and ionic bonds with the matrix of the poly(VBA-co-VBTAC) nanobers. At the same time, there were no additional characteristic absorption bands for drug-loaded poly(VBA-co-VBTAC)/ciprooxacin nanobers elucidating that there was no noticeable chemical reaction between the drug and the nanober matrix. This is an important indication that ciprooxacin would keep its activity in the poly(VBA-co-VBTAC)/ciprooxacin nanobrous matrix. The X-ray diffraction (XRD) patterns of ciprooxacin and the nanobrous mats of poly(VBA-co-VBTAC) and poly(VBA-co-VBTAC)/ciprooxacin are depicted in Fig. 4 . Ciprooxacin is a crystalline material having salient peaks centered at 2q ¼ 14 ,
and 25 . Poly(VBA-co-VBTAC) is an amorphous polymer
showing a broad halo diffraction pattern. The absence of any diffraction peak of crystalline ciprooxacin in the XRD pattern of poly(VBA-co-VBTAC)/ciprooxacin nanobers indicated that the ciprooxacin molecules were distributed in the nanobers without forming any crystalline aggregates. Rashkov et al. have reported crystal aggregates of ciprooxacin hydrochloride when encapsulated in poly(L-lactide-co-D,L-lactide) (coPLA) or coPLA/ PEG electrospun nanobers, yet, in that study higher weight load of drugs (10-30 wt%) was used, more importantly, ciprooxacin hydrochloride was not soluble in electrospinning solution where a milky white suspension was obtained and electrospun thereaer. 37 In our case, the ciprooxacin was soluble in the electrospinning solution forming a homogeneous and clear solution with the polymer matrix. So, the rapid evaporation of solvent during the electrospinning process yielded amorphous dispersion of a crystalline drug in the electrospun polymeric ber matrix as also reported for other electrospun drug-polymer nanober systems.
38,39 Moreover, in Table 1 The characteristics of poly(VBA-co-VBTAC) and poly(VBA-co-VBTAC)/ciprofloxacin solutions and the resulting electrospun fibers our case, the hydrogen bonds between the drug molecules and the polymer matrix possibly hindered the phase separation and crystal aggregation of ciprooxacin throughout the poly(VBA-co-VBTAC) matrix and therefore resulted in an amorphous phase.
Drug release from pH responsive nanobers
Ciprooxacin is a broad-spectrum uoroquinolone antibacterial agent used in the treatment of both Gram-positive and Gram-negative microorganisms. Ciprooxacin was chosen as a model drug for investigating the pH responsive release ability of electrospun poly(VBA-co-VBTAC) nanobers. The loading efficiency of nanobers loaded with 5% (w/w, with respect to polymer) ciprooxacin was determined to be 93.4 AE 3.4%. Fig. 5 shows the cumulative drug release (%) from poly(VBA-co-VBTAC) pH responsive nanobers encapsulating ciprooxacin into three different release media having different pH values; acetate buffer solution (pH ¼ 5.2), phosphate buffered saline (pH ¼ 7.4) and tris-buffered saline (pH ¼ 8.8). Two stages of release can be distinguished in the release proles; aer a quick initial release which continued for 30 minutes, the following time interval showed sustained release of ciprooxacin from a nanobrous matrix up to 240 minutes for acetate buffer solution and 480 minutes for phosphate buffered saline and trisbuffered saline. No further drug release was observed aer 240 minutes into acetate buffer solution; whereas aer 480 minutes no more drug was released into phosphate buffered saline and tris-buffered saline.
It is a known fact that the release of a drug from a polymeric matrix is mainly controlled by diffusion of the drug and/or degradation of the matrix. The observed drug release was attributed mainly to the diffusion or permeation of drug through the polymer matrix. Since the time period of our experiment (720 minutes) is not long enough to observe degradation of polymer. In addition, as seen from the SEM images of nanobers taken aer release experiment (Fig. 6) , the ber morphology of the poly(VBA-co-VBTAC) was retained aer the release experiments were carried out in acetate buffer solution, phosphate buffered saline and tris-buffered saline.
The release behaviors of drug are closely related to the distribution of the drug within the matrix. Moreover, the solubility and compatibility of the drug in the drug-polymer-solvent system is of great importance in the release behavior of drugs from polymeric nanobers. Therefore, when the drug is hydrophilic and the polymer is hydrophobic or vice versa, and/or the drug is not soluble in electrospinning solution, most of the drug will be localized near the surface of nanobers due to the phase separation and lack of the sufficient physical interaction between the drug and the polymer matrix. This situation leads to quite high initial burst release. 40, 41 However, in our case both ciprooxacin and poly(VBA-co-VBTAC) are hydrophobic, so they are compatible; and ciprooxacin is soluble in DMF-acetic acid (7/3) solution. Therefore, initial burst release was not so high. This may be due to the increasing intermolecular and/or intramolecular interactions. An initial burst release is required for the delivery of antibiotic drugs aiming to prevent bacterial proliferation at the initial stage; whereas, for a few organisms that manage to survive, sustained release is also needed for antibiotics. 41 Here, the sustained release of ciprooxacin was observed as well. The total release amount of ciprooxacin from nanobers was more in acetate buffer solution compared to phosphate buffer saline and tris-buffered saline. The poly(VBAco-VBTAC) includes cationic VBTAC units and pH-responsive VBA units. This might be due to the weak electrostatic interaction between VBA and VBTAC units at lower pHs which are below the pK a . In our previous study, we showed that the pK a of poly(VBA-co-VBTAC) polymer brushes on silicon wafer surfaces was 7.65. 33 On the other hand, Gabaston et al. and Liu and Armes reported that the pK a value of VBA homopolymer was 4.4 and 7.1, respectively. 42, 43 The total release amount of ciprooxacin from nanobers was decreased with increasing pH, because of the increasing electrostatic interactions. The remaining ciprooxacin content in nanobers may originate from this interaction as well. In brief, our electrospun poly(VBAco-VBTAC) nanobers encapsulating ciprooxacin could present a rapid enough release for bacteria not to proliferate at rst stage but could provide a sustained release as well owing to the diffusion mechanism dominating in release of ciprooxacin from nanobers.
Conclusions
In conclusion, pH-responsive poly(VBA-co-VBTAC) nanobers encapsulating ciprooxacin were successfully prepared via electrospinning techniques for the purpose of controlled drug release systems. SEM imaging proved that the electrospinning of nanobers from poly(VBA-co-VBTAC) was successful and encapsulation of ciprooxacin did not affect the morphology of the nanobers where a bead-free and smooth ber morphology was observed for both poly(VBA-co-VBTAC) and poly(VBA-co-VBTAC)/ciprooxacin nanobers. The presence of ciprooxacin in the poly(VBA-co-VBTAC) nanobers was conrmed by FTIR spectroscopy. XRD data suggested that ciprooxacin was homogeneously distributed within the poly(VBA-co-VBTAC) nanobers without forming phase separated crystalline aggregates. Results of in vitro release experiments suggested that the poly(VBA-co-VBTAC)/ciprooxacin nanobers were capable of effectively delivering ciprooxacin in a controlled fashion with prolonged duration depending on the pH. The initial burst release was higher with increasing pH values, because of the increasing intermolecular and/or intramolecular interactions. However, the total release amount of ciprooxacin from nanobers was more in acetate buffer solution compared to higher pH values. This pH-responsive poly(VBA-co-VBTAC) nanobers may provide opportunities to develop innovative responsive materials for various applications. For instance, our newly developed pH responsive nanobers may be potentially useful for controlled drug delivery and biomedical engineering.
